Oxford Biotrans Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Out of Business

Oxford Biotrans General Information

Description

Developer of enzymatic process technologies designed to yield large-value chemical compounds. The company uses a patented cytochrome P450 enzyme technology that helps to gain natural-grade products from natural feedstocks, offers the security of supply by using readily available feedstocks, and also realizes production cost, enabling companies to avail environmentally friendly ingredients that produce less chemical waste and uses less energy.

Contact Information

Website
www.oxfordbiotrans.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 30 Upper High Street
  • Thame OX9 3EZ
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Specialty Chemicals
Agricultural Chemicals
Vertical(s)
Life Sciences
Corporate Office
  • 30 Upper High Street
  • Thame OX9 3EZ
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oxford Biotrans Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Out of Business 20-Aug-2024 Completed Out of Business
10. Later Stage VC Completed Generating Revenue
9. Grant 01-Nov-2020 Completed Generating Revenue
8. Later Stage VC 12-Aug-2019 Completed Generating Revenue
7. Grant 01-Jun-2018 Completed Generating Revenue
6. Early Stage VC 10-Oct-2017 Completed Generating Revenue
5. Grant 01-Mar-2017 Completed Generating Revenue
4. Early Stage VC (Series A) 04-Aug-2015 Completed Generating Revenue
3. Seed Round 22-Jan-2014 $1.32M $1.32M Completed Generating Revenue
2. Seed Round Completed Startup
To view Oxford Biotrans’s complete valuation and funding history, request access »

Oxford Biotrans Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary A
Seed Preferred
Seed Preferred
Ordinary A
Seed Preferred 7,378 $0.012319 $335.07 $335.07 1x $335.07 25.47%
Seed Preferred 4,000 $0.012319 $246.37 $246.37 1x $246.37 13.81%
To view Oxford Biotrans’s complete cap table history, request access »

Oxford Biotrans Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of enzymatic process technologies designed to yield large-value chemical compounds. The company uses a patente
Biotechnology
Thame, United Kingdom
5 As of 2024

Emeryville, CA
 

Visalia, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Oxford Biotrans Competitors (14)

One of Oxford Biotrans’s 14 competitors is Amyris (Biotechnology), a Private Equity-Backed company based in Emeryville, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amyris (Biotechnology) Private Equity-Backed Emeryville, CA
Edeniq Venture Capital-Backed Visalia, CA
Manus Venture Capital-Backed Waltham, MA
Plumino Precision Fermentation Europe Corporation Düsseldorf, Germany
Lygos Venture Capital-Backed Hayward, CA
You’re viewing 5 of 14 competitors. Get the full list »

Oxford Biotrans Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Oxford Biotrans Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-3084351-A Combined bed and lounge Inactive 13-Mar-1961
US-2962334-A Filler strip for knock-down sectional furniture Inactive 08-Jul-1958

Oxford Biotrans Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Oxford Biotrans FAQs

  • When was Oxford Biotrans founded?

    Oxford Biotrans was founded in 2013.

  • Where is Oxford Biotrans headquartered?

    Oxford Biotrans is headquartered in Thame, United Kingdom.

  • What is the size of Oxford Biotrans?

    Oxford Biotrans has 5 total employees.

  • What industry is Oxford Biotrans in?

    Oxford Biotrans’s primary industry is Biotechnology.

  • Is Oxford Biotrans a private or public company?

    Oxford Biotrans is a Private company.

  • What is Oxford Biotrans’s current revenue?

    The current revenue for Oxford Biotrans is .

  • How much funding has Oxford Biotrans raised over time?

    Oxford Biotrans has raised $10.1M.

  • Who are Oxford Biotrans’s competitors?

    Amyris (Biotechnology), Edeniq, Manus, Plumino Precision Fermentation Europe, and Lygos are some of the 14 competitors of Oxford Biotrans.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process